Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bianca Cuffa"'
Autor:
Valentina Giudice, Luca Pezzullo, Giuseppe Ciancia, Matteo D'Addona, Francesca D'Alto, Marisa Gorrese, Bianca Cuffa, Carmine Selleri
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 14, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/10881da236e34336b6e79fd8229eb162
Autor:
Valentina Giudice, Pasquale Pagliano, Alessandro Vatrella, Alfonso Masullo, Sergio Poto, Benedetto Maria Polverino, Renato Gammaldi, Angelantonio Maglio, Carmine Sellitto, Carolina Vitale, Bianca Serio, Bianca Cuffa, Anna Borrelli, Carmine Vecchione, Amelia Filippelli, Carmine Selleri
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
To date, there are no specific therapeutic strategies for treatment of COVID-19. Based on the hypothesis that complement and coagulation cascades are activated by viral infection, and might trigger an acute respiratory distress syndrome (ARDS), we re
Externí odkaz:
https://doaj.org/article/71dc2009fb144324b729553711024285
Autor:
Marisa Gorrese, Angela Bertolini, Lucia Fresolone, Annapaola Campana, Luca Pezzullo, Roberto Guariglia, Laura Mettivier, Paola Manzo, Bianca Cuffa, Francesca D'Alto, Bianca Serio, Carmine Selleri, Valentina Giudice
Publikováno v:
Journal of immunological methods. 511
Harmonization of flow cytometry protocols from instrument settings to antibody panel and reagents is highly encouraged for inter-laboratory data comparison in both research and clinical settings, especially for minimal residual disease monitoring eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4683e9f93abbdc60d76ee6396b8362b
https://pubmed.ncbi.nlm.nih.gov/36243108
https://pubmed.ncbi.nlm.nih.gov/36243108
Autor:
Serena Luponio, Angela Bertolini, Francesca D'Alto, Bianca Cuffa, Bianca Serio, Roberto Guariglia, Carmine Selleri, Laura Mettivier, Idalucia Ferrara, L Pezzullo, Marisa Gorrese, Valentina Giudice, Matteo D'Addona, Danilo De Novellis
Publikováno v:
Blood. 138:4339-4339
Treatment of acute myeloid leukemia (AML) in elderly is still challenging. Indeed, high-dose chemotherapy followed by hematopoietic stem cell transplantation with myeloablative regimens is not always feasible because patients are often unfit and have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1623c46ea449bd393114010695181d4
https://doi.org/10.1182/blood-2021-150484
https://doi.org/10.1182/blood-2021-150484